| Results date | November 04, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 7,397.79 Cr (+12.76% YoY, +0.85% QoQ) |
| Previous quarter PAT | Rs. 348.87 Cr (down 44.71% QoQ) |
| Previous quarter EBITDA margin | 11.7% |
| Market cap | Rs. 24,098.91 Cr |
| CMP | Rs. 379.45 |
The Board of Directors meets on November 4, 2026, to consider the Q2/H1 FY27 un-audited financial results (standalone & consolidated) and NCD fundraising via private placement under Section 180(1)(c), subject to postal ballot approval.
The Q2 FY27 analyst conference call is scheduled for November 5, 2026, at 3:30 PM IST, and the transcript is to be filed with the exchanges.
The Q2 FY27 print will test whether Apollo Tyres' calibrated price increases can keep pace with an escalating raw-material cycle: natural rubber moved from ~Rs. 275/kg in June 2026 to record levels near Rs. 290/kg by late October, while Brent monthly averages climbed from ~$84/b in July to $114/b in September and the rupee slid to ~95.82 against the dollar by September 22.
Demand, by contrast, is not the constraint — FADA retail printed record months (July +25.89% YoY, August +17.51%, September +31.82%), feeding the replacement channel that is 79% of Apollo's mix, while India utilization at 90–91% means revenue is gated by capacity, with management having guided that India stays capacity-constrained throughout FY27.
Management had already called its Q1 price hike of 6–8% 'insufficient' if commodity prices persist, anticipating 'at least two additional rounds'; the Q2 India tranche (guided ~9% in TBR and ~11% in other categories, within the 15–16% cumulative Q1–Q2 program) only partially offsets the guided ~8% sequential RM-basket increase, and the company entered Q2 holding higher-cost inventory after a Rs. 419 Cr Q1 inventory build.
In Europe, the Enschede-to-Hungary capacity shift completes by September–October 2026 with P&L benefits expected from H2 FY'27, and only 3–4% of the needed 10% Europe price increase was done as of the Q1 call. The upcoming call will also be watched for the margin bridge versus Q1's 11.7% EBITDA margin, the capex step-up against the Rs. 35 billion FY27 plan, and who presents the numbers after CFO Gaurav Kumar's October 6, 2026 exit with no successor disclosed.
Performance vs Guidance Tracking
Q2 margin bridge and raw-material pass-through: The central swing factor of the quarter is the price/cost catch-up lag.
CFO transition and governance
India capacity and demand supply-gating
Management has guided to 'high teens EBITDA on a full-year basis' for European operations post the move to Hungary, with restructuring benefits expected from H2 FY'27. Ex-overlaps, European margins would be 'about 11% odd' today, per the CFO.
CFO Gaurav Kumar said: 'We definitely believe that in a normalised scenario, we will get back to a 16% which was our earlier normal, and in fact, we believe we can even surpass that.' This is framed as a normalised, mid-to-long-term scenario.
Management estimates TBR replacement share at upwards of 30%, indicating a recovery to previous levels, and PCR replacement share at over 21% (Q1 FY27 call). In Europe, replacement market share is under 3%, with gains expected 'only in decimals'.
The Enschede closure carries estimated FY27 cash outflows of EUR 55 million, already provided for, and a 5–6% revenue impact in the previously loss-making agricultural/OHT OE segment. Production stopped in June 2026, with the 750,000-tyre Netherlands capacity shifting to Hungary and India by September–October 2026.
Management has implemented a cumulative 15–16% price increase in India replacement across Q1–Q2 FY27 (7–9% taken in Q1; a further 9% in TBR and 11% in other categories in Q2). However, management stated the 6–8% Q1 hike 'will be insufficient if commodity prices remain at current levels,' anticipating at least two additional rounds.
Disclaimer: This earnings preview is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.